The Value of Serum MicroRNA-21-5p and LncRNAgadd7 Expression Levels in Predicting the Severity and Prognosis of ARDS ( Acute Respiratory Distress Syndrome )
CompletedOBSERVATIONAL
Enrollment
110
Participants
Timeline
Start Date
November 1, 2023
Primary Completion Date
November 30, 2024
Study Completion Date
January 10, 2025
Conditions
Acute Respiratory Distress Syndrome
Trial Locations (1)
563100
Affiliated Hospital of Zunyi Medical University, Zunyi
All Listed Sponsors
lead
Shao Yuekai
OTHER
NCT06825754 - The Value of Serum MicroRNA-21-5p and LncRNAgadd7 Expression Levels in Predicting the Severity and Prognosis of ARDS ( Acute Respiratory Distress Syndrome ) | Biotech Hunter | Biotech Hunter